Feng Yan, Chang Pan, Liu Jin, Zhang Wen-Sheng
Department of Anesthesiology, Affiliated Hospital of North Sichuan Medical College, China; Department of Anesthesiology, West China Hospital, Sichuan University, China; Laboratory of Anesthesia and Critical Care Medicine, National-Local Joint Engineering Research Centre of Translational Medicine of Anesthesiology, West China Hospital, Sichuan University, China.
Department of Anesthesiology, West China Hospital, Sichuan University, China; Laboratory of Anesthesia and Critical Care Medicine, National-Local Joint Engineering Research Centre of Translational Medicine of Anesthesiology, West China Hospital, Sichuan University, China.
J Clin Anesth. 2024 Jun;94:111367. doi: 10.1016/j.jclinane.2023.111367. Epub 2024 Jan 16.
The adrenal gland is a vital endocrine organ, and adrenal steroid synthesis and secretion are closely regulated by the hypothalamic-pituitary-adrenal (HPA) axis in response to various stimuli. Surgery or trauma can activate the HPA axis and induce the secretion of cortisol. Different cortisol responses vary with the grade of surgery. Perioperative medications have the potential to decrease the cortisol level in the body, and both excessive and insufficient cortisol levels after surgery are disadvantageous. The effect of perioperative medications on the HPA response to surgery can be divided into three levels: "adrenal insufficiency (AI)", "stress response inhibition", and "uncertainty". The clinical presentation of AI includes fatigue, nausea, vomiting, abdominal pain, muscle cramps, hypotension, hypovolemic shock and prerenal failure, which may result in fatal consequences. Stress response inhibition can reduce postoperative complications, such as pain and cognitive dysfunction. This is protective to patients during perioperative and postoperative periods. The aim of the present review is to shed light on current evidence regarding the exact effects and mechanisms of perioperative medications on the HPA response to surgical injury and provide the applicable guidance on clinical anesthesia.
肾上腺是一个重要的内分泌器官,肾上腺类固醇的合成和分泌受到下丘脑-垂体-肾上腺(HPA)轴的密切调节,以应对各种刺激。手术或创伤可激活HPA轴并诱导皮质醇分泌。不同的皮质醇反应因手术等级而异。围手术期用药有可能降低体内皮质醇水平,术后皮质醇水平过高或过低均不利。围手术期用药对HPA对手术反应的影响可分为三个层面:“肾上腺功能不全(AI)”、“应激反应抑制”和“不确定性”。AI的临床表现包括疲劳、恶心、呕吐、腹痛、肌肉痉挛、低血压、低血容量性休克和肾前性衰竭,可能导致致命后果。应激反应抑制可减少术后并发症,如疼痛和认知功能障碍。这在围手术期和术后对患者具有保护作用。本综述的目的是阐明关于围手术期用药对HPA对手术损伤反应的确切影响和机制的现有证据,并为临床麻醉提供适用的指导。